Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 70 entries
Sorted by: Best Match Show Resources per page
A dedicated compression device for high resolution X-ray tomography of compressed gas diffusion layers.

The Review of scientific instruments

Tötzke C, Manke I, Gaiselmann G, Bohner J, Müller BR, Kupsch A, Hentschel MP, Schmidt V, Banhart J, Lehnert W.
PMID: 25933863
Rev Sci Instrum. 2015 Apr;86(4):043702. doi: 10.1063/1.4918291.

We present an experimental approach to study the three-dimensional microstructure of gas diffusion layer (GDL) materials under realistic compression conditions. A dedicated compression device was designed that allows for synchrotron-tomographic investigation of circular samples under well-defined compression conditions. The...

Cite
Tötzke C, Manke I, Gaiselmann G, et al. A dedicated compression device for high resolution X-ray tomography of compressed gas diffusion layers. Rev Sci Instrum. 2015;86(4):043702doi: 10.1063/1.4918291.
Tötzke, C., Manke, I., Gaiselmann, G., Bohner, J., Müller, B. R., Kupsch, A., Hentschel, M. P., Schmidt, V., Banhart, J., & Lehnert, W. (2015). A dedicated compression device for high resolution X-ray tomography of compressed gas diffusion layers. The Review of scientific instruments, 86(4), 043702. https://doi.org/10.1063/1.4918291
Tötzke, C, et al. "A dedicated compression device for high resolution X-ray tomography of compressed gas diffusion layers." The Review of scientific instruments vol. 86,4 (2015): 043702. doi: https://doi.org/10.1063/1.4918291
Tötzke C, Manke I, Gaiselmann G, Bohner J, Müller BR, Kupsch A, Hentschel MP, Schmidt V, Banhart J, Lehnert W. A dedicated compression device for high resolution X-ray tomography of compressed gas diffusion layers. Rev Sci Instrum. 2015 Apr;86(4):043702. doi: 10.1063/1.4918291. PMID: 25933863.
Copy Download .nbib Format: NLM
IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics.

European psychiatry : the journal of the Association of European Psychiatrists

Kasper S, Tauscher J, Küfferle E, Hesselmann B, Barnas C, Brücke T.
PMID: 19698668
Eur Psychiatry. 1998;13:9s-14s.

Considerable progress has been achieved over the past 15 years in uncovering the biological basis of major psychiatric disorders. Since psychopharmacological treatment is thought to act on the underlying biological basis of the disease, brain imaging techniques enable us...

Cite
Kasper S, Tauscher J, Küfferle E, et al. IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics. Eur Psychiatry. 1998;13:9s-14s
Kasper, S., Tauscher, J., Küfferle, E., Hesselmann, B., Barnas, C., & Brücke, T. (1998). IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics. European psychiatry : the journal of the Association of European Psychiatrists, 139s-14s.
Kasper, S, et al. "IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics." European psychiatry : the journal of the Association of European Psychiatrists vol. 13 (1998): 9s-14s.
Kasper S, Tauscher J, Küfferle E, Hesselmann B, Barnas C, Brücke T. IBZM-SPECT imaging of dopamine D(2) receptors with typical and atypical antipsychotics. Eur Psychiatry. 1998;13:9s-14s. PMID: 19698668.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Gieselmann G.
PMID: 30937783
MMW Fortschr Med. 2019 Apr;161(6):26. doi: 10.1007/s15006-019-0344-8.

No abstract available.

Cite
Gieselmann G. Rodeo auf dem Bürokratieschimmel. . MMW Fortschr Med. 2019;161(6):26doi: 10.1007/s15006-019-0344-8.
Gieselmann, G. (2019). Rodeo auf dem Bürokratieschimmel. . MMW Fortschritte der Medizin, 161(6), 26. https://doi.org/10.1007/s15006-019-0344-8
Gieselmann, Gisela. "Rodeo auf dem Bürokratieschimmel." . MMW Fortschritte der Medizin vol. 161,6 (2019): 26. doi: https://doi.org/10.1007/s15006-019-0344-8
Gieselmann G. Rodeo auf dem Bürokratieschimmel. . MMW Fortschr Med. 2019 Apr;161(6):26. doi: 10.1007/s15006-019-0344-8. German. PMID: 30937783.
Copy Download .nbib Format: NLM
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.

Cell host & microbe

Vanshylla K, Fan C, Wunsch M, Poopalasingam N, Meijers M, Kreer C, Kleipass F, Ruchnewitz D, Ercanoglu MS, Gruell H, Münn F, Pohl K, Janicki H, Nolden T, Bartl S, Stein SC, Augustin M, Dewald F, Gieselmann L, Schommers P, Schulz TF, Sander LE, Koch M, Łuksza M, Lässig M, Bjorkman PJ, Klein F.
PMID: 34973165
Cell Host Microbe. 2022 Jan 12;30(1):69-82.e10. doi: 10.1016/j.chom.2021.12.010. Epub 2021 Dec 18.

A fraction of COVID-19 convalescent individuals mount a potent antibody response to SARS-CoV-2 with cross-reactivity to SARS-CoV-1. To uncover their humoral response in detail, we performed single B cell analysis from 10 SARS-CoV-2 elite neutralizers. We isolated and analyzed...

Cite
Vanshylla K, Fan C, Wunsch M, et al. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell Host Microbe. 2021;30(1):69-82.e10doi: 10.1016/j.chom.2021.12.010.
Vanshylla, K., Fan, C., Wunsch, M., Poopalasingam, N., Meijers, M., Kreer, C., Kleipass, F., Ruchnewitz, D., Ercanoglu, M. S., Gruell, H., Münn, F., Pohl, K., Janicki, H., Nolden, T., Bartl, S., Stein, S. C., Augustin, M., Dewald, F., Gieselmann, L., Schommers, P., Schulz, T. F., Sander, L. E., Koch, M., Łuksza, M., Lässig, M., Bjorkman, P. J., & Klein, F. (2022). Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell host & microbe, 30(1), 69-82.e10. https://doi.org/10.1016/j.chom.2021.12.010
Vanshylla, Kanika, et al. "Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers." Cell host & microbe vol. 30,1 (2022): 69-82.e10. doi: https://doi.org/10.1016/j.chom.2021.12.010
Vanshylla K, Fan C, Wunsch M, Poopalasingam N, Meijers M, Kreer C, Kleipass F, Ruchnewitz D, Ercanoglu MS, Gruell H, Münn F, Pohl K, Janicki H, Nolden T, Bartl S, Stein SC, Augustin M, Dewald F, Gieselmann L, Schommers P, Schulz TF, Sander LE, Koch M, Łuksza M, Lässig M, Bjorkman PJ, Klein F. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell Host Microbe. 2022 Jan 12;30(1):69-82.e10. doi: 10.1016/j.chom.2021.12.010. Epub 2021 Dec 18. PMID: 34973165; PMCID: PMC8683262.
Copy Download .nbib Format: NLM
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.

Cell host & microbe

Vanshylla K, Fan C, Wunsch M, Poopalasingam N, Meijers M, Kreer C, Kleipass F, Ruchnewitz D, Ercanoglu MS, Gruell H, Münn F, Pohl K, Janicki H, Nolden T, Bartl S, Stein SC, Augustin M, Dewald F, Gieselmann L, Schommers P, Schulz TF, Sander LE, Koch M, Łuksza M, Lässig M, Bjorkman PJ, Klein F.
PMID: 34973165
Cell Host Microbe. 2021 Dec 18; doi: 10.1016/j.chom.2021.12.010. Epub 2021 Dec 18.

A fraction of COVID-19 convalescent individuals mount a potent antibody response to SARS-CoV-2 with cross-reactivity to SARS-CoV-1. To uncover their humoral response in detail, we performed single B cell analysis from 10 SARS-CoV-2 elite neutralizers. We isolated and analyzed...

Cite
Vanshylla K, Fan C, Wunsch M, et al. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell Host Microbe. 2021;doi: 10.1016/j.chom.2021.12.010.
Vanshylla, K., Fan, C., Wunsch, M., Poopalasingam, N., Meijers, M., Kreer, C., Kleipass, F., Ruchnewitz, D., Ercanoglu, M. S., Gruell, H., Münn, F., Pohl, K., Janicki, H., Nolden, T., Bartl, S., Stein, S. C., Augustin, M., Dewald, F., Gieselmann, L., Schommers, P., Schulz, T. F., Sander, L. E., Koch, M., Łuksza, M., Lässig, M., Bjorkman, P. J., & Klein, F. (2021). Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell host & microbe, . https://doi.org/10.1016/j.chom.2021.12.010
Vanshylla, Kanika, et al. "Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers." Cell host & microbe vol. (2021). doi: https://doi.org/10.1016/j.chom.2021.12.010
Vanshylla K, Fan C, Wunsch M, Poopalasingam N, Meijers M, Kreer C, Kleipass F, Ruchnewitz D, Ercanoglu MS, Gruell H, Münn F, Pohl K, Janicki H, Nolden T, Bartl S, Stein SC, Augustin M, Dewald F, Gieselmann L, Schommers P, Schulz TF, Sander LE, Koch M, Łuksza M, Lässig M, Bjorkman PJ, Klein F. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell Host Microbe. 2021 Dec 18; doi: 10.1016/j.chom.2021.12.010. Epub 2021 Dec 18. PMID: 34973165; PMCID: PMC8683262.
Copy Download .nbib Format: NLM
Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers.

Cell host & microbe

Vanshylla K, Fan C, Wunsch M, Poopalasingam N, Meijers M, Kreer C, Kleipass F, Ruchnewitz D, Ercanoglu MS, Gruell H, Münn F, Pohl K, Janicki H, Nolden T, Bartl S, Stein SC, Augustin M, Dewald F, Gieselmann L, Schommers P, Schulz TF, Sander LE, Koch M, Łuksza M, Lässig M, Bjorkman PJ, Klein F.
PMID: 34973165
Cell Host Microbe. 2021 Dec 18; doi: 10.1016/j.chom.2021.12.010. Epub 2021 Dec 18.

A fraction of COVID-19 convalescent individuals mount a potent antibody response to SARS-CoV-2 with cross-reactivity to SARS-CoV-1. To uncover their humoral response in detail, we performed single B cell analysis from 10 SARS-CoV-2 elite neutralizers. We isolated and analyzed...

Cite
Vanshylla K, Fan C, Wunsch M, et al. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell Host Microbe. 2021;doi: 10.1016/j.chom.2021.12.010.
Vanshylla, K., Fan, C., Wunsch, M., Poopalasingam, N., Meijers, M., Kreer, C., Kleipass, F., Ruchnewitz, D., Ercanoglu, M. S., Gruell, H., Münn, F., Pohl, K., Janicki, H., Nolden, T., Bartl, S., Stein, S. C., Augustin, M., Dewald, F., Gieselmann, L., Schommers, P., Schulz, T. F., Sander, L. E., Koch, M., Łuksza, M., Lässig, M., Bjorkman, P. J., & Klein, F. (2021). Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell host & microbe, . https://doi.org/10.1016/j.chom.2021.12.010
Vanshylla, Kanika, et al. "Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers." Cell host & microbe vol. (2021). doi: https://doi.org/10.1016/j.chom.2021.12.010
Vanshylla K, Fan C, Wunsch M, Poopalasingam N, Meijers M, Kreer C, Kleipass F, Ruchnewitz D, Ercanoglu MS, Gruell H, Münn F, Pohl K, Janicki H, Nolden T, Bartl S, Stein SC, Augustin M, Dewald F, Gieselmann L, Schommers P, Schulz TF, Sander LE, Koch M, Łuksza M, Lässig M, Bjorkman PJ, Klein F. Discovery of ultrapotent broadly neutralizing antibodies from SARS-CoV-2 elite neutralizers. Cell Host Microbe. 2021 Dec 18; doi: 10.1016/j.chom.2021.12.010. Epub 2021 Dec 18. PMID: 34973165; PMCID: PMC8683262.
Copy Download .nbib Format: NLM
What Is the Comparison in Robot Time per Screw, Radiation Exposure, Robot Abandonment, Screw Accuracy, and Clinical Outcomes Between Percutaneous and Open Robot-Assisted Short Lumbar Fusion?: A Multicenter, Propensity-Matched Analysis of 310 Patients.

Spine

Lee NJ, Buchanan IA, Zuckermann SL, Boddapati V, Mathew J, Geiselmann M, Park PJ, Leung E, Buchholz AL, Khan A, Mullin J, Pollina J, Jazini E, Haines C, Schuler TC, Good CR, Lombardi JM, Lehman RA.
PMID: 34091564
Spine (Phila Pa 1976). 2022 Jan 01;47(1):42-48. doi: 10.1097/BRS.0000000000004132.

STUDY DESIGN: Multicenter cohort.OBJECTIVE: To compare the robot time/screw, radiation exposure, robot abandonment, screw accuracy, and 90-day outcomes between robot-assisted percutaneous and robot-assisted open approach for short lumbar fusion (1- and 2-level).SUMMARY OF BACKGROUND DATA: There is conflicting literature...

Cite
Lee NJ, Buchanan IA, Zuckermann SL, et al. What Is the Comparison in Robot Time per Screw, Radiation Exposure, Robot Abandonment, Screw Accuracy, and Clinical Outcomes Between Percutaneous and Open Robot-Assisted Short Lumbar Fusion?: A Multicenter, Propensity-Matched Analysis of 310 Patients. Spine (Phila Pa 1976). 2022;47(1):42-48doi: 10.1097/BRS.0000000000004132.
Lee, N. J., Buchanan, I. A., Zuckermann, S. L., Boddapati, V., Mathew, J., Geiselmann, M., Park, P. J., Leung, E., Buchholz, A. L., Khan, A., Mullin, J., Pollina, J., Jazini, E., Haines, C., Schuler, T. C., Good, C. R., Lombardi, J. M., & Lehman, R. A. (2022). What Is the Comparison in Robot Time per Screw, Radiation Exposure, Robot Abandonment, Screw Accuracy, and Clinical Outcomes Between Percutaneous and Open Robot-Assisted Short Lumbar Fusion?: A Multicenter, Propensity-Matched Analysis of 310 Patients. Spine, 47(1), 42-48. https://doi.org/10.1097/BRS.0000000000004132
Lee, Nathan J, et al. "What Is the Comparison in Robot Time per Screw, Radiation Exposure, Robot Abandonment, Screw Accuracy, and Clinical Outcomes Between Percutaneous and Open Robot-Assisted Short Lumbar Fusion?: A Multicenter, Propensity-Matched Analysis of 310 Patients." Spine vol. 47,1 (2022): 42-48. doi: https://doi.org/10.1097/BRS.0000000000004132
Lee NJ, Buchanan IA, Zuckermann SL, Boddapati V, Mathew J, Geiselmann M, Park PJ, Leung E, Buchholz AL, Khan A, Mullin J, Pollina J, Jazini E, Haines C, Schuler TC, Good CR, Lombardi JM, Lehman RA. What Is the Comparison in Robot Time per Screw, Radiation Exposure, Robot Abandonment, Screw Accuracy, and Clinical Outcomes Between Percutaneous and Open Robot-Assisted Short Lumbar Fusion?: A Multicenter, Propensity-Matched Analysis of 310 Patients. Spine (Phila Pa 1976). 2022 Jan 01;47(1):42-48. doi: 10.1097/BRS.0000000000004132. PMID: 34091564.
Copy Download .nbib Format: NLM
Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study.

The Lancet regional health. Europe

Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, Horn C, Vanshylla K, Cristanziano VD, Osebold L, Roventa M, Riaz T, Tschernoster N, Altmueller J, Rose L, Salomon S, Priesner V, Luers JC, Albus C, Rosenkranz S, Gathof B, Fätkenheuer G, Hallek M, Klein F, Suárez I, Lehmann C.
PMID: 34027514
Lancet Reg Health Eur. 2021 Jul;6:100122. doi: 10.1016/j.lanepe.2021.100122. Epub 2021 May 18.

BACKGROUND: While the leading symptoms during coronavirus disease 2019 (COVID-19) are acute and the majority of patients fully recover, a significant fraction of patients now increasingly experience long-term health consequences. However, most data available focus on health-related events after...

Cite
Augustin M, Schommers P, Stecher M, et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021;6:100122doi: 10.1016/j.lanepe.2021.100122.
Augustin, M., Schommers, P., Stecher, M., Dewald, F., Gieselmann, L., Gruell, H., Horn, C., Vanshylla, K., Cristanziano, V. D., Osebold, L., Roventa, M., Riaz, T., Tschernoster, N., Altmueller, J., Rose, L., Salomon, S., Priesner, V., Luers, J. C., Albus, C., Rosenkranz, S., Gathof, B., Fätkenheuer, G., Hallek, M., Klein, F., Suárez, I., & Lehmann, C. (2021). Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. The Lancet regional health. Europe, 6100122. https://doi.org/10.1016/j.lanepe.2021.100122
Augustin, Max, et al. "Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study." The Lancet regional health. Europe vol. 6 (2021): 100122. doi: https://doi.org/10.1016/j.lanepe.2021.100122
Augustin M, Schommers P, Stecher M, Dewald F, Gieselmann L, Gruell H, Horn C, Vanshylla K, Cristanziano VD, Osebold L, Roventa M, Riaz T, Tschernoster N, Altmueller J, Rose L, Salomon S, Priesner V, Luers JC, Albus C, Rosenkranz S, Gathof B, Fätkenheuer G, Hallek M, Klein F, Suárez I, Lehmann C. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Reg Health Eur. 2021 Jul;6:100122. doi: 10.1016/j.lanepe.2021.100122. Epub 2021 May 18. PMID: 34027514; PMCID: PMC8129613.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Gieselmann G.
PMID: 33961255
MMW Fortschr Med. 2021 May;163(9):35. doi: 10.1007/s15006-021-9936-1.

No abstract available.

Cite
Gieselmann G. Mal auf die Priorisierung pfeifen. . MMW Fortschr Med. 2021;163(9):35doi: 10.1007/s15006-021-9936-1.
Gieselmann, G. (2021). Mal auf die Priorisierung pfeifen. . MMW Fortschritte der Medizin, 163(9), 35. https://doi.org/10.1007/s15006-021-9936-1
Gieselmann, Gisela. "Mal auf die Priorisierung pfeifen." . MMW Fortschritte der Medizin vol. 163,9 (2021): 35. doi: https://doi.org/10.1007/s15006-021-9936-1
Gieselmann G. Mal auf die Priorisierung pfeifen. . MMW Fortschr Med. 2021 May;163(9):35. doi: 10.1007/s15006-021-9936-1. German. PMID: 33961255.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Gieselmann G.
PMID: 33464503
MMW Fortschr Med. 2021 Jan;163(1):33. doi: 10.1007/s15006-020-9520-0.

No abstract available.

Cite
Gieselmann G. Rezept her, Frau Doktor - Miezi braucht ihre Tropfen! . MMW Fortschr Med. 2021;163(1):33doi: 10.1007/s15006-020-9520-0.
Gieselmann, G. (2021). Rezept her, Frau Doktor - Miezi braucht ihre Tropfen! . MMW Fortschritte der Medizin, 163(1), 33. https://doi.org/10.1007/s15006-020-9520-0
Gieselmann, Gisela. "Rezept her, Frau Doktor - Miezi braucht ihre Tropfen!" . MMW Fortschritte der Medizin vol. 163,1 (2021): 33. doi: https://doi.org/10.1007/s15006-020-9520-0
Gieselmann G. Rezept her, Frau Doktor - Miezi braucht ihre Tropfen! . MMW Fortschr Med. 2021 Jan;163(1):33. doi: 10.1007/s15006-020-9520-0. German. PMID: 33464503.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Gieselmann G.
PMID: 32405843
MMW Fortschr Med. 2020 May;162(9):35. doi: 10.1007/s15006-020-0473-0.

No abstract available.

Cite
Gieselmann G. Patienten sollten gut in Mathe sein. . MMW Fortschr Med. 2020;162(9):35doi: 10.1007/s15006-020-0473-0.
Gieselmann, G. (2020). Patienten sollten gut in Mathe sein. . MMW Fortschritte der Medizin, 162(9), 35. https://doi.org/10.1007/s15006-020-0473-0
Gieselmann, Gisela. "Patienten sollten gut in Mathe sein." . MMW Fortschritte der Medizin vol. 162,9 (2020): 35. doi: https://doi.org/10.1007/s15006-020-0473-0
Gieselmann G. Patienten sollten gut in Mathe sein. . MMW Fortschr Med. 2020 May;162(9):35. doi: 10.1007/s15006-020-0473-0. German. PMID: 32405843.
Copy Download .nbib Format: NLM
[No title available]

MMW Fortschritte der Medizin

Gieselmann G.
PMID: 32248477
MMW Fortschr Med. 2020 Apr;162(6):39. doi: 10.1007/s15006-020-0334-x.

No abstract available.

Cite
Gieselmann G. Ich lege mir ein radioaktiv strahlendes Lächeln zu : Für manche ganz spezielle Patienten. . MMW Fortschr Med. 2020;162(6):39doi: 10.1007/s15006-020-0334-x.
Gieselmann, G. (2020). Ich lege mir ein radioaktiv strahlendes Lächeln zu : Für manche ganz spezielle Patienten. . MMW Fortschritte der Medizin, 162(6), 39. https://doi.org/10.1007/s15006-020-0334-x
Gieselmann, Gisela. "Ich lege mir ein radioaktiv strahlendes Lächeln zu : Für manche ganz spezielle Patienten." . MMW Fortschritte der Medizin vol. 162,6 (2020): 39. doi: https://doi.org/10.1007/s15006-020-0334-x
Gieselmann G. Ich lege mir ein radioaktiv strahlendes Lächeln zu : Für manche ganz spezielle Patienten. . MMW Fortschr Med. 2020 Apr;162(6):39. doi: 10.1007/s15006-020-0334-x. German. PMID: 32248477.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 70 entries